{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:59:38Z","timestamp":1769003978046,"version":"3.49.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"5","funder":[{"name":"AVIR Pharma Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2022,7,4]]},"DOI":"10.1080\/14737167.2021.1981862","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T18:57:29Z","timestamp":1631732249000},"page":"805-814","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-5430","authenticated-orcid":false,"given":"C.","family":"Beauchemin","sequence":"first","affiliation":[{"name":"Facult\u00e9 de Pharmacie, Universit\u00e9 de Montreal, Montreal, Canada"},{"name":"PeriPharm Inc, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-1178","authenticated-orcid":false,"given":"K.","family":"Guinan","sequence":"additional","affiliation":[{"name":"PeriPharm Inc, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-1122","authenticated-orcid":false,"given":"D.","family":"Claveau","sequence":"additional","affiliation":[{"name":"Medical Affairs, AVIR Pharma Inc, Blainville, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2486-5813","authenticated-orcid":false,"given":"S. Fr\u00e9d\u00e9ric","family":"Dufresne","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Clinical Microbiology, Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, Canada"},{"name":"Department of Microbiology, Immunology and Infectious Diseases, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-0968","authenticated-orcid":false,"given":"C.","family":"Rotstein","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Infectious Diseases Service, Division of Infectious Diseases, Department of Medicine, University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/308169"},{"key":"e_1_3_6_4_1","unstructured":"Centers for Disease Control and Prevention. Fungal diseases 2017 [cited 2018 Jun 1]. Available from: https:\/\/www.cdc.gov\/fungal\/infections\/index.html"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis195"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-316430"},{"key":"e_1_3_6_7_1","volume-title":"Harrison\u2019s principles of internal medicine","author":"Denning D.","year":"2015","unstructured":"Denning D. Aspergillosis. In: Kasper D, Fauci A, Hauser S et al., editors Harrison\u2019s principles of internal medicine. 19e ed. New York (NY): McGraw-Hill Education; 2015.","edition":"19"},{"key":"e_1_3_6_8_1","volume-title":"Harrison\u2019s principles of internal medicine","author":"Spellberg B","year":"2015","unstructured":"Spellberg B, Ibrahim A. Mucormycosis. In: Kasper D, Fauci A, Hauser S, et al. editors. Harrison\u2019s principles of internal medicine. 19e ed. New York (NY): McGraw-Hill Education; 2015.","edition":"19"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.07.011"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03020"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/590004"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.152900"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S145545"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00071-2"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1638789"},{"key":"e_1_3_6_20_1","unstructured":"Ellison LF. Progress in net cancer survival in Canada over 20 years. Health Ref. 2018. 29(9):10-18."},{"issue":"50","key":"e_1_3_6_21_1","article-title":"Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study","volume":"8","author":"Beusterien K","year":"2010","unstructured":"Beusterien K, Davies J, Leach M, et al. Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study. Health Qual Life Outcomes. 2010;8(50):50.","journal-title":"Health Qual Life Outcomes"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12324"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03908.x"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12631"},{"key":"e_1_3_6_25_1","unstructured":"Statistics Canada. Consumer price index annual average not seasonally adjusted (Table: 18-10-0005-01). 2020 [cited 2018 Jun 1]. Available from: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/cv.action?pid=1810000501"},{"key":"e_1_3_6_26_1","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Guidelines for the economic evaluation of health technologies: Canada 4th edition 2017 [cited 2018 Jun 1]. Available from: https:\/\/www.cadth.ca\/guidelines-economic-evaluation-health-technologies-canada-4th-edition"},{"key":"e_1_3_6_27_1","unstructured":"Ontario. Ontario Drug Benefit Formulary. 2019 [cited 2018 Jun 1]. Available from: https:\/\/www.formulary.health.gov.on.ca\/formulary\/"},{"key":"e_1_3_6_29_1","unstructured":"Canadian Institute for Health Information. Patient cost estimator 2019 [cited 2018 Jun 1]. Available from: https:\/\/www.cihi.ca\/en\/patient-cost-estimator"},{"key":"e_1_3_6_30_1","unstructured":"Ontario. Ontario Care Costing (OCC)- Cost analysis tool 2020 [cited 2018 Jun 1]. Available from: https:\/\/hsimi.ca\/occp\/occpreports\/"},{"key":"e_1_3_6_31_1","unstructured":"Statistics Canada. Average usual hours and wages by selected characteristics monthly unadjusted for seasonality last 5 months (Table: 14-10-0320-01). 2020 [cited 2018 Jun 1]. Available from: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1410032001"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00850.x"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm196"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01141.x"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040446"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-2922-y"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00489.x"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X167327"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1638789"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw099"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2021.1981862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:10:16Z","timestamp":1731042616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2021.1981862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7,4]]}},"alternative-id":["10.1080\/14737167.2021.1981862"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2021.1981862","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}